Back to KROS
GEODE CAPITAL MANAGEMENT, LLC → KROS
GEODE CAPITAL MANAGEMENT, LLC KROS Position History
Keros Therapeutics, Inc. • Healthcare
Quarters held
10
Latest value
$879K
Q3 2026
Peak value
$11.6M
First seen
Q3 2025
Dollar value over time
Show data table
| Period | Position value |
|---|---|
| Q3 2025 | $11.6M |
| Q3 2025 | $1.7M |
| Q4 2025 | $11.4M |
| Q4 2025 | $1.6M |
| Q1 2026 | $6.6M |
| Q1 2026 | $907K |
| Q2 2026 | $4.7M |
| Q2 2026 | $773K |
| Q3 2026 | $4.8M |
| Q3 2026 | $879K |
Quarter-by-quarter history
Every disclosed snapshot of the position
| Quarter | Value | Shares | % Portfolio | Change |
|---|---|---|---|---|
| Q3 2026 | $879K | 77.1K | — | — |
| Q3 2026 | $4.8M | 419.1K | — | — |
| Q2 2026 | $773K | 72.3K | — | — |
| Q2 2026 | $4.7M | 438.6K | — | — |
| Q1 2026 | $907K | 82.2K | — | — |
| Q1 2026 | $6.6M | 599.3K | — | — |
| Q4 2025 | $1.6M | 77.7K | — | — |
| Q4 2025 | $11.4M | 557.5K | — | — |
| Q3 2025 | $1.7M | 105.4K | — | — |
| Q3 2025 | $11.6M | 731.9K | — | — |